NCT06730308View on ClinicalTrials.gov

Glucocorticoids Combined With Concurrent Chemoradiotherapy for Unresectable Thymoma

PHASE2RecruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

November 20, 2024

Primary Completion Date

November 19, 2028

Study Completion Date

November 19, 2028

Conditions
Thymoma
Interventions
RADIATION

Radiotherapy

Hypofractionated radiotherapy

DRUG

Concurrent chemotherapy

weekly albumin-bound paclitaxel (50 mg/m²) and cisplatin (25 mg/m²)

DRUG

Methylprednisolone

Methylprednisolone 2mg/kg, qd, concurrent with radiotherapy

Trial Locations (1)

510000

RECRUITING

Sun yat-sen University Cancer Center, Guanzhou

All Listed Sponsors
lead

Sun Yat-sen University

OTHER